Upstaza™ Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Upstaza™ (eladocagene exuparvovec) was granted authorization by the Medicines and...

Related Keywords

Northern Ireland ,Craigavon ,United Kingdom ,Norway ,Iceland ,United States ,Liechtenstein ,Great Britain ,Jeanine Clemente ,Kylie Okeefe ,Stuartw Peltz ,Kirsty Hoyle ,Administration Of Upstaza ,Nasdaq ,Lancet Child Adolesc Health ,Child Neurology Society ,Therapeutics Inc ,European Union ,Healthcare Products Regulatory Agency ,Chief Executive Officer ,Metabolic Support United ,More Information ,Private Securities Litigation Reform Act ,Annual Report ,Annual Meeting ,Lancet Child Adolesc ,Ptc Therapeutics ,Nc ,